Diabetes charity Diabetes UK has linked up with Bristol-Myers Squibb and AstraZeneca to launch a nationwide patient survey. The aim of the study is to find out more about hypoglycaemia . Together, the pharmaceutical companies will start to market a type 2 diabetes drug called Onglyza later on this year.
The patient survey is timed to fit in with Diabetes Week next week. Chief Executive of Diabetes UK, Douglas Smallwood, reportedly commented: "Although we already know a lot about severe hypoglycaemia, little has been done to investigate mild-to-moderate episodes, which people can experience on a regular basis."
The medical director of Astrazeneca UK, Dr. Yeoman, was meanwhile reported in the media as saying: "We hope the results of the survey will raise the understanding and awareness of mild-to-moderate hypos and lead to the improved management of type II diabetes across the UK."
New diabetes patient survey
Fri, 19 Jun 2009
Recommended links
Diabetes based financial servicesDiabetes forum
Diabetes myLifestyle
Diabetes donate
Diabetes signs and symptoms
Cannabis could treat diabetes
Diabetes prescription cost
Universal celiac testing in USA good news for diabetes patients
Depression occurring amongst young diabetes patients
High-risk diabetes patients targeted
Twice weekly fish could help diabetes patients
Diabetes patients suffering from depression
Patients with diabetes and heart conditions could use statin therapy
Gum disease treatment for diabetes patients
Medication given to diabetes patients too early
Arthritis causes diabetes patients not to exercise
Canadian diabetes patients wait on exubera
Psychological support from nurses could help diabetes patients
The patient holds the key in diabetes treatment
Takeda diabetes drug patient fractures
Weight Loss for Diabetes Patients Crucial
Mentally ill diabetic patients at greater risk
Rosiglitazone patients should see doctors, American Diabetes Association say
New NHS budgets could benefit diabetes patients
Aspirin use for diabetes patients under question
Self-testing for diabetes may not benefit patients
Patients in new AtheroGenics trial
Diabetes patients find limited use in online records
Type 2 diabetes patients should get CBT from nurses and GPs
Charity warning for type 2 diabetes patients
Low bone density for female diabetes patients
GPs will take on pre-diabetes patients
Diabetes doubles risk of liver cancer in some patients
Indians High Risk Diabetes Patients
New hope for diabetes patients from cell transplant
Join us